Tanju Kapagan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Palliative Care

Urinary Incontinence

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Archives of Iranian medicine

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

American journal of therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem, Suleyman Yıldırım, Zeynep Betul Erdem, Halil Sahin
Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review. Archives of Iranian medicine 27 (3) (2024)
Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem, Suleyman Yıldırım, Zeynep Betul Erdem, Halil Sahin
Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review. Archives of Iranian medicine 27 (3) (2024)
Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem, Suleyman Yıldırım, Zeynep Betul Erdem, Halil Sahin
Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review. Archives of Iranian medicine 27 (3) (2024)
Tanju Kapagan, Nilufer Bulut, Ahmet Ünsal, Gokmen Umut Erdem
Sorafenib-Associated Bilateral Osteonecrosis of the Femoral Head. American journal of therapeutics 31 (5) (2024)
Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem, Suleyman Yıldırım, Zeynep Betul Erdem, Halil Sahin
Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review. Archives of Iranian medicine 27 (3) (2024)
Kubilay Karaboyun, Eyyüp Cavdar, Yakup İriağaç, Abdussamet Celebı, Tanju Kapagan, Ilkay Gulturk, Ozden Demır, Okan Avcı, Erdoğan Selçuk Şeber
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (6) (2023)
Kubilay Karaboyun, Eyyüp Cavdar, Yakup İriağaç, Abdussamet Celebı, Tanju Kapagan, Ilkay Gulturk, Ozden Demır, Okan Avcı, Erdoğan Selçuk Şeber
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (6) (2023)
Tanju Kapagan, Nilufer Bulut, Serhat Demirer, Gokmen Umut Erdem
Ribociclib-induced visual hallucination in a patient with metastatic breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Kubilay Karaboyun, Eyyüp Cavdar, Yakup İriağaç, Abdussamet Celebı, Tanju Kapagan, Ilkay Gulturk, Ozden Demır, Okan Avcı, Erdoğan Selçuk Şeber
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (6) (2023)
Kubilay Karaboyun, Eyyüp Cavdar, Yakup İriağaç, Abdussamet Celebı, Tanju Kapagan, Ilkay Gulturk, Ozden Demır, Okan Avcı, Erdoğan Selçuk Şeber
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (6) (2023)
Tanju Kapagan, Faruk Aksu, Sabahattin Yuzkan, Nilufer Bulut, Gokmen Umut Erdem
Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)